Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

β-Arrestin–Mediated Angiotensin II Type 1 Receptor Activation Promotes Pulmonary Vascular Remodeling in Pulmonary Hypertension
Zhiyuan Ma, Gayathri Viswanathan, Mason Sellig, et al.
JACC Basic to Translational Science (2021) Vol. 6, Iss. 11, pp. 854-869
Open Access | Times Cited: 19

Showing 19 citing articles:

Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association
Sudarshan Rajagopal, Kurt Ruetzler, Kamrouz Ghadimi, et al.
Circulation (2023) Vol. 147, Iss. 17, pp. 1317-1343
Open Access | Times Cited: 51
Angiotensin II: A novel biomarker in vascular diseases
Qinyi Zhou, Jing Pan, Wang Liu, et al.
Clinica Chimica Acta (2025) Vol. 568, pp. 120154-120154
Closed Access | Times Cited: 1
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
Kanika Verma, Malvika Pant, Sarvesh Paliwal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
The AT1/AT2 Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System
Mélissa Colin, Céline Delaitre, Sébastien Foulquier, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5481-5481
Open Access | Times Cited: 14
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes
Katarina Zeder, Edward D. Siew, Gábor Kovács, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 11, pp. 742-754
Closed Access | Times Cited: 5
Biomimetic Nanoparticle-Mediated Target Delivery of Hypoxia-Responsive Plasmid of Angiotensin-Converting Enzyme 2 to Reverse Hypoxic Pulmonary Hypertension
Rui Yuan, Manling Liu, Ying Cheng, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 8204-8222
Closed Access | Times Cited: 12
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors
András Dávid Tóth, Gábor Turu, László Hunyady
Nature Reviews Nephrology (2024) Vol. 20, Iss. 11, pp. 722-741
Closed Access | Times Cited: 4
β-Arrestin 2 as a Prognostic Indicator and Immunomodulatory Factor in Multiple Myeloma
Parker Mathews, Xiaobei Wang, Jian Wu, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 496-496
Open Access
Distinct Mechanisms of β-Arrestin–Biased Agonist and Blocker of AT1R in Preventing Aortic Aneurysm and Associated Mortality
Zaira Palomino Jara, Terri J. Harford, Khuraijam Dhanachandra Singh, et al.
Hypertension (2022) Vol. 80, Iss. 2, pp. 385-402
Open Access | Times Cited: 14
Angiotensin II induces endothelial dysfunction and vascular remodeling by downregulating TRPV4 channels
Narendra Babu Kondapalli, Katari Venkatesh, Kesha Dalal, et al.
Journal of Molecular and Cellular Cardiology Plus (2023) Vol. 6, pp. 100055-100055
Open Access | Times Cited: 7
Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood–Brain Barrier
Graham J. Moore, Harry Ridway, Laura Kate Gadanec, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5779-5779
Open Access | Times Cited: 2
Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome
Irene Valdivia Callejon, Lucia Buccioli, Jarl Bastianen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5025-5025
Open Access | Times Cited: 1
Implications of β-Arrestin biased signaling by angiotensin II type 1 receptor for cardiovascular drug discovery and therapeutics
Khuraijam Dhanachandra Singh, Sadashiva S. Karnik
Cellular Signalling (2024) Vol. 124, pp. 111410-111410
Open Access | Times Cited: 1
Biased Signaling Agonists Promote Distinct Phosphorylation and Conformational States of the Dopamine D3 Receptor
Binod Nepal, Jessica Barnett, Frank Bearoff, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10470-10470
Open Access | Times Cited: 1
Comparative evaluation of biased agonists Sarcosine1, d‐Alanine8‐Angiotensin (Ang) II (SD Ang II) and Sarcosine1, Isoleucine8‐Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT1 receptors
Natalia M. Noto, Yazmin M. Restrepo, Hong Weng Pang, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 2
De novopurine synthesis: a new target in pulmonary arterial hypertension?
Gayathri Viswanathan, Sudarshan Rajagopal
European Heart Journal (2023) Vol. 44, Iss. 14, pp. 1280-1282
Closed Access | Times Cited: 2
Naodesheng decoction regulating vascular function via G-protein-coupled receptors: network analysis and experimental investigations
Shuhan Chen, Ziran Niu, Yanjia Shen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Perioperative Anesthetic Management in Repair Diaphragmatic Hernia with Atrial Septal Defect and Pulmonary Hypertension
M. Irvan Noorrahman, Pratama Ananda, Novita Anggraeni
Indonesian Journal of Anesthesiology and Reanimation (2024) Vol. 6, Iss. 2, pp. 106-115
Open Access
It’s Time to Put the Term “Pulmonary Vasodilators” to Rest
Lewis J. Rubin
JACC Basic to Translational Science (2021) Vol. 6, Iss. 11, pp. 870-871
Open Access | Times Cited: 1
Page 1

Scroll to top